Stocks and Investing
Stocks and Investing
Tue, October 6, 2020
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Mon, October 5, 2020
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Timothy Chiang Upgraded (AMPH) to Buy on, Oct 5th, 2020
Timothy Chiang of Northland Capital Markets, Upgraded "Amphastar Pharmaceuticals, Inc." (AMPH) to Buy on, Oct 5th, 2020.
Timothy has made no other calls on AMPH in the last 4 months.
There is 1 other peer that has a rating on AMPH. Out of the 1 peers that are also analyzing AMPH, all agrees with Timothy's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Tim Chiang of "Northland Capital Markets" Downgraded from Buy to Hold and Held Target at $23 on, Thursday, July 9th, 2020